Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 27, 456-461, March 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferrer, J. F.
Right arrow Articles by Mihich, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrer, J. F.
Right arrow Articles by Mihich, E.

Dependence of the Regression of Sarcoma 180 in Vitamin B6- deficient Mice upon the Immunologic Competence of the Host1

J. F. Ferrer2 and E. Mihich

Department of Experimental Therapeutics, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14203

The incidence of complete regression of Sarcoma 180 (S-180) in vitamin B6-deficient Swiss mice was significantly reduced in animals thymectomized 1–5 days after birth but not in sham-thymectomized mice, neonatally thymectomized mice implanted s.c. with thymus autografts, mice thymectomized 9 or 30 days after birth, or neonatally splenectomized mice. The initial retardation of the growth of S-180 caused by the dietary depletion was not different in neonatally thymectomized and sham-operated mice; the delayed retardation of tumor growth was reduced in mice which had been thymectomized neonatally. Thus in nonthymectomized mice the delayed retardation of tumor growth appears to be caused by both the therapeutic treatment and the immunologic response of the host.

Comparison of the regression of S-180 and the rejection of allogenic skin grafts indicated that dietary vitamin B6 depletion causes only minor impairment of the immunologic responses of the host at levels sufficient to impair the tumor effectively.

1 This investigation was supported in part by a research grant (CA 04130) from the National Cancer Institute, USPHS, and by an Institutional Research Grant (I-SOI-FR-5562-03) from the USPHS.

2 Present address: Department of Radiology, Stanford University Medical School, during the tenure of an Eleanor Roosevelt International Cancer Fellowship from the International Union Against Cancer.

Received 6/27/66. Accepted 10/ 3/66.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1967 by the American Association for Cancer Research.